AUROBINDO PHARMA
Back to Cashflow Statement
|
AUROBINDO PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,925 Cr | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr | ₹3,329 Cr |
What is the latest Cash Flow from Operating Activities ratio of AUROBINDO PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹3,925 Cr |
| Mar2024 | ₹2,435 Cr |
| Mar2023 | ₹2,387 Cr |
| Mar2022 | ₹5,016 Cr |
| Mar2021 | ₹3,329 Cr |
How is Cash Flow from Operating Activities of AUROBINDO PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,925 Cr | 61.21 | |
| Mar2024 | ₹2,435 Cr | 2.00 | |
| Mar2023 | ₹2,387 Cr | -52.42 | |
| Mar2022 | ₹5,016 Cr | 50.69 | |
| Mar2021 | ₹3,329 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹86,404.9 Cr | 0.9% | 8.3% | 23.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 3.2% | 12.5% | 10.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 2.9% | 8.5% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | 0.3% | 5.7% | 36.3% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 10.4% | 15.9% | -5.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.8% | 9% | 10.8% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.9% |
8.3% |
23.6% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses